Teligent Total Liabilities 2010-2021 | TLGT
Teligent total liabilities from 2010 to 2021. Total liabilities can be defined as the total value of all possible claims against the corporation.
Teligent Annual Total Liabilities
(Millions of US $) |
| 2020 |
$198 |
| 2019 |
$212 |
| 2018 |
$172 |
| 2017 |
$140 |
| 2016 |
$127 |
| 2015 |
$114 |
| 2014 |
$158 |
| 2013 |
$8 |
| 2012 |
$3 |
| 2011 |
$2 |
| 2010 |
$1 |
| 2009 |
$1 |
Teligent Quarterly Total Liabilities
(Millions of US $) |
| 2021-06-30 |
$134 |
| 2021-03-31 |
$133 |
| 2020-12-31 |
$198 |
| 2020-09-30 |
$230 |
| 2020-06-30 |
$228 |
| 2020-03-31 |
$219 |
| 2019-12-31 |
$212 |
| 2019-09-30 |
$196 |
| 2019-06-30 |
$188 |
| 2019-03-31 |
$182 |
| 2018-12-31 |
$172 |
| 2018-09-30 |
$157 |
| 2018-06-30 |
$148 |
| 2018-03-31 |
$141 |
| 2017-12-31 |
$140 |
| 2017-09-30 |
$144 |
| 2017-06-30 |
$138 |
| 2017-03-31 |
$132 |
| 2016-12-31 |
$127 |
| 2016-09-30 |
$125 |
| 2016-06-30 |
$124 |
| 2016-03-31 |
$122 |
| 2015-12-31 |
$114 |
| 2015-09-30 |
$115 |
| 2015-06-30 |
$120 |
| 2015-03-31 |
$153 |
| 2014-12-31 |
$158 |
| 2014-09-30 |
$15 |
| 2014-06-30 |
$8 |
| 2014-03-31 |
$7 |
| 2013-12-31 |
$8 |
| 2013-09-30 |
$6 |
| 2013-06-30 |
$5 |
| 2013-03-31 |
$4 |
| 2012-12-31 |
$3 |
| 2012-09-30 |
$2 |
| 2012-06-30 |
$2 |
| 2012-03-31 |
$2 |
| 2011-12-31 |
$2 |
| 2011-09-30 |
$2 |
| 2011-06-30 |
$1 |
| 2011-03-31 |
$2 |
| 2010-12-31 |
$1 |
| 2010-09-30 |
$1 |
| 2010-06-30 |
$1 |
| 2010-03-31 |
$1 |
| 2009-12-31 |
$1 |
| 2009-09-30 |
$1 |
| 2009-06-30 |
$1 |
| 2009-03-31 |
$6 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
|
